experimental vaccine
The Latest
-
Remdesivir A Major Flop In Global Vaccine Test Made By WHO
But Gilead Sciences said the results did not mean the vaccine is useless. But Gilead Sciences said the results did not mean the vaccine is useless. -
Gilead Sciences' Remdesivir Speeds COVID Recovery Time: Study
Remdesivir has been granted emergency use authorization by the U.S. Food and Drug Administration for treating patients hospitalized for the virus. Remdesivir has been granted emergency use authorization by the U.S. Food and Drug Administration for treating patients hospitalized for the virus. -
Brazil, AstraZeneca Sign $127 Million Deal To Produce Experimental COVID-19 Drug
Experimental vaccine developed by AstraZeneca shown to be effective in combating COVID-19. Experimental vaccine developed by AstraZeneca shown to be effective in combating COVID-19. -
AstraZeneca To Supply Europe With 400 Million COVID-19 Vaccines
China, Russia, Brazil, and Japan expressed interest, as well, AstraZeneca CEO said. China, Russia, Brazil, and Japan expressed interest, as well, AstraZeneca CEO said. -
Pfizer, BioNTech Test US Adults With Experimental Vaccine Vs Coronavirus
Pfizer could develop millions of doses of Covid-19 vaccines by end of the year Pfizer could develop millions of doses of Covid-19 vaccines by end of the year -
Gilead CEO Says Company Has Been Exporting Remdesivir For Clinical Trials
Remdesivir is the first vaccine to show positive results in treating Covid-19 since discovery of novel coronavirus in China. Remdesivir is the first vaccine to show positive results in treating Covid-19 since discovery of novel coronavirus in China. -
Gilead's Experimental Drug Improves 50% Of Patients In Prelim Tests
Fauci said medication shortened the time it takes for patients to recover by 31 percent Fauci said medication shortened the time it takes for patients to recover by 31 percent -
Chinese Doctors Stop Gilead Sciences Remdesivir Test In China
Capital Medical University and Chinese Academy of Medical Sciences shut down remdesivir trials Capital Medical University and Chinese Academy of Medical Sciences shut down remdesivir trials -
Sanofi Pledges 100 Million Doses Of Hydroxychloroquine To Contain COVID-19
Several nations, including the US, use hydroxychloroquine as an emergency measure against Covid-19 Several nations, including the US, use hydroxychloroquine as an emergency measure against Covid-19 -
Gilead Donates 1.5 Million Doses Of Experimental Drug Remdesevir
Remdesivir deemed the most promising therapeutic vaccine, based on current evidence on human and animal studies. Remdesivir deemed the most promising therapeutic vaccine, based on current evidence on human and animal studies.